OMOlav Muren

Olav Muren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olav Muren has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Denosumab for treating periprosthetic osteolysis; study protocol for a randomized, double-blind, placebo-controlled trial

    by Olof Sköldenberg, Agata Rysinska, Thomas Eisler, Mats Salemyr, Henrik Bodén, Olle Muren

    Wear-induced osteolysis is the main factor in reducing the longevity of total hip arthroplasty (THA). The transmembrane Receptor Activator of Nuclear Factor κ B (RANK) and its corresponding ligand RANKL is an important regulator of osteoclast activity and bone resorption and is associated with osteolysis around implant. Inhibiting RANKL with denosumab is effective in vivo in preventing osteoporosis-related fractures. In vitro, osteoclasts can be blocked in animal models of osteolysis. We hypothesize that denosumab is effective in reducing wear-induced osteolysis around uncemented acetabular implants in THA. A randomized, double-blind, placebo-controlled trial will be conducted. We will include 110 patients, 40–85 years of age, with a known osteolytic lesion around an uncemented acetabular component ≥7 years after the primary operation. The patients will be randomized in a 1:1 ratio to subcutaneous injections of 60 mg denosumab or placebo for a total of 6 doses with start on day one and every 6 months with last treatment at 30 months. The primary endpoint will be the change in volume of the osteolytic lesion at 3 years measured with three-dimensional computed tomography (3D-CT). Secondary endpoints include functional outcome scores, change in bone mineral density of the lumbar spine, serological markers of bone turnover and adverse events. In vitro results of both bisphosphonates and RANKL inhibitors have been promising, showing reduced osteolysis with treatment. This is, to our knowledge, the first clinical trial testing the efficacy of denosumab in reducing wear-induced osteolysis. The study is an academic, phase II trial from an independent center and is designed to demonstrate efficacy in reducing volume of osteolytic lesions around a total hip arthroplasty. ClinicalTrials.gov ( NCT02299817 ) 2014-11-20


  • Open Access

    Good stability but high periprosthetic bone mineral loss and late-occurring periprosthetic fractures with use of uncemented tapered femoral stems in patients with a femoral neck fracture

    by Olof G Sköldenberg, Helene Sjöö, Paula Kelly-Pettersson, Henrik Bodén, Thomas Eisler, André Stark, Olle Muren

    We previously evaluated a new uncemented femoral stem designed for elderly patients with a femoral neck fracture and found stable implant fixation and good clinical results up to 2 years postoperatively, despite substantial periprosthetic bone mineral loss. We now present the medium-term follow-up results from this study. In this observational prospective cohort study, we included 50 patients (mean age 81 (70-92) years) with a femoral neck fracture. All patients underwent surgery with a cemented cup and an uncemented stem specifically designed for fracture treatment. Outcome variables were migration of the stem measured with radiostereometry (RSA) and periprosthetic change in bone mineral density (BMD), measured with dual-energy X-ray absorptiometry (DXA). Hip function and health-related quality of life were assessed using the Harris hip score (HHS) and the EuroQol-5D (EQ-5D). DXA and RSA data were collected at regular intervals up to 4 years, and data concerning reoperations and hip-related complications were collected during a mean follow-up time of 5 (0.2-7.5) years. At 5 years, 19 patients had either passed away or were unavailable for further participation and 31 could be followed up. Of the original 50 patients, 6 patients had suffered a periprosthetic fracture, all of them sustained after the 2-year follow-up. In 19 patients, we obtained complete RSA and DXA data and no component had migrated after the 2-year follow-up. We also found a continuous total periprosthetic bone loss amounting to a median of -19% (-39 to 2). No changes in HHS or EQ-5D were observed during the follow-up period. In this medium-term follow-up, the stem remained firmly fixed in bone despite considerable periprosthetic bone mineral loss. However, this bone loss might explain the high number of late-occurring periprosthetic fractures. Based on these results, we would not recommend uncemented femoral stems for the treatment of femoral neck fractures in the elderly.


  • Open Access

    Retrospective record review in proactive patient safety work – identification of no-harm incidents

    by Kristina Schildmeijer, Maria Unbeck, Olav Muren, Joep Perk, Karin Pukk Härenstam, Lena Nilsson

    In contrast to other safety critical industries, well-developed systems to monitor safety within the healthcare system remain limited. Retrospective record review is one way of identifying adverse events in healthcare. In proactive patient safety work, retrospective record review could be used to identify, analyze and gain information and knowledge about no-harm incidents and deficiencies in healthcare processes. The aim of the study was to evaluate retrospective record review for the detection and characterization of no-harm incidents, and compare findings with conventional incident-reporting systems. A two-stage structured retrospective record review of no-harm incidents was performed on a random sample of 350 admissions at a Swedish orthopedic department. Results were compared with those found in one local, and four national incident-reporting systems. We identified 118 no-harm incidents in 91 (26.0%) of the 350 records by retrospective record review. Ninety-four (79.7%) no-harm incidents were classified as preventable. The five incident-reporting systems identified 16 no-harm incidents, of which ten were also found by retrospective record review. The most common no-harm incidents were related to drug therapy (n = 66), of which 87.9% were regarded as preventable. No-harm incidents are common and often preventable. Retrospective record review seems to be a valuable tool for identifying and characterizing no-harm incidents. Both harm and no-harm incidents can be identified in parallel during the same record review. By adding a retrospective record review of randomly selected records to conventional incident-reporting, health care providers can gain a clearer and broader picture of commonly occurring, no-harm incidents in order to improve patient safety.


  • Open Access

    Is detection of adverse events affected by record review methodology? an evaluation of the “Harvard Medical Practice Study” method and the “Global Trigger Tool”

    by Maria Unbeck, Kristina Schildmeijer, Peter Henriksson, Urban Jürgensen, Olav Muren, Lena Nilsson, Karin Pukk Härenstam

    There has been a theoretical debate as to which retrospective record review method is the most valid, reliable, cost efficient and feasible for detecting adverse events. The aim of the present study was to evaluate the feasibility and capability of two common retrospective record review methods, the “Harvard Medical Practice Study” method and the “Global Trigger Tool” in detecting adverse events in adult orthopaedic inpatients.


  • Open Access

    Healthcare processes must be improved to reduce the occurrence of orthopaedic adverse events

    by Maria Unbeck, Nils Dalen, Olav Muren, Ulf Lillkrona, Karin Pukk Härenstam

    The great benefits of modern healthcare must be weighed against the risk of patient injury due to human intervention. Studies show that adverse events (AE) are identified in up to 16.6% of all hospitalisations. As a step toward preventing AEs, efforts are made to collect patient safety information at different levels in the healthcare systems. The information is neither effectively organised nor integrated within the healthcare systems, leading to difficulty achieving systematic analysis. This may be due to the use of different methods that yield qualitatively different information about AE. The general aim of this thesis was to evaluate the capability of retrospective record review (RRR) methods to identify patient safety and quality information in orthopaedic care. In papers I and II, 395 patient records were retrospectively examined for AEs using both traditional incident reporting methods and RRR for the same cohort. More AEs were identified using RRR than by using traditional incident reporting methods. Also, paper II showed that more AEs were due to deficiencies in care processes rather than to deficiencies in technical skills. In paper III, the efficiency of an orthopaedic nursing improvement initiative, called “improvement theme months,” was evaluated using case study methodology and a RRR of 2,281 patients. Results showed significant improvement over time in performance of risk assessment for pressure ulcers and lowered pressure ulcer prevalence. We found RRR easy to use and valuable as a method to assess improvement over time. In paper IV, the RRR methods Harvard Medical Practice Study (HMPS) and Global Trigger Tool (GTT) were compared for capability to identify AEs in a sample of 350 randomly selected orthopaedic admissions. Results showed that HMPS identified more AEs than GTT did. The overall positive predictive value was 40% and 30% for HMPS and GTT methods, respectively. Retrospective record review appears to achieve wider coverage when identifying orthopaedic AEs at a local level. Given that many current methods vary considerably in quality of data gathered and in coverage, which require multiple methods to be used concurrently, the wider coverage characteristic of RRR is an advantage. Consequently, RRR could play a vital role in quality and safety information systems in order to identify, categorise, and analyse quality and patient safety problems and to provide the basis for interventions. Increased awareness, consideration of risk factors, interventions focused on multidisciplinary and interdepartmental teamwork, and strategies that focus on healthcare processes may reduce the frequency of AEs in orthopaedic care. Also, RRR can incorporate a time series display of patient safety intervention outcomes to drive change. As a method, improvement theme months may serve to organise quality and lead to safety improvement in nursing. However, we found that it was associated with a lengthy period of time before new guidelines, quality indicators, and safety initiatives were noticed and became widely used in clinical practice. To achieve sustainable and significant improvement, interventions on many levels of the organisation were needed


  • Open Access

    Gross osteolytic tibia tunnel widening with the use of Gore-Tex anterior cruciate ligament prosthesis

    by Olle Muren, Lars Dahlstedt, Eva Brosjö, Mats Dahlborn, Nils Dalén

    Postoperative widening of the bone tunnels have been found after anterior cruciate ligament reconstruction using autologus bone-patellar tendon-bone or hamstring tendon grafts. These changes seem to be of no clinical significance in a short to midterm follow-up. We investigated if a synthetic graft evokes the same bone tunnel widening and if it is of clinical significance in a longterm follow-up. We examined 17 patients, 13-15 years after their anterior cruciate ligament reconstruction using a Gore-Tex ligament prosthesis. The follow-up consisted of clinical examination, K-1000 arthrometric measurement, Tegner, Lysholm and IKDC scores, and CT examination of their tibia bone tunnels. 6 patients had been reoperated before follow-up, 3 because of graft rupture and 3 because of effusion and/or pain. 5 patients were graded as normal (n = 2) or nearly normal according to the IKDC score, and 4 of these patients still had their Gore-Tex prosthesis intact. 15 of the patients had a tibia bone tunnel wider than the drilled 7.9 mm diameter, ranging from 9.6 to 26 mm. These changes in the bone tunnels were in some cases without symptoms and could not be detected with arthroscopy, clinical examination, arthrometry or evaluation scores. We do not know whether they are progressive. Based on our findings, we recommend that patients who have had a Gore-Tex anterior cruciate ligament reconstruction should be examined not only clinically or by questionnaire, but also with CT.